{"id":"W4392640282","doi":"10.1016/j.ejca.2024.114001","title":"Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?","year":2024,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Institut Gustave-Roussy; Agence Nationale de Sécurité du Médicament et des Produits de Santé; Institute of Cancer Research; National Science Foundation; Institut National Du Cancer; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Medicine; Chemotherapy; Oncology; Immunotherapy; Internal medicine; Neuroblastoma; BETA (programming language); Cancer; Computer science; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056191,0.0000847197,0.0002770334,0.00009038789,0.0001869117,0.000272207,0.0001559534,0.0001474146,0.0005486474],"category_scores_gemma":[0.0006213108,0.00005732672,0.0001830284,0.0001965384,0.0001623627,0.0001847146,0.0001662416,0.0002681408,0.00008992519],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005458237,"about_ca_system_score_gemma":0.0005636466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001084357,"about_ca_topic_score_gemma":0.003931275,"domain_scores_codex":[0.9998327,0.0000661154,0.00001745973,0.00003530219,0.00002325047,0.00002520221],"domain_scores_gemma":[0.9996479,0.0000811286,0.0001522061,0.00001214716,0.00001895793,0.00008776168],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01420872,0.0007559798,0.8537292,0.00026013,0.0002350868,0.0005859728,0.0003598895,0.0008422291,0.007275944,0.0001086463,0.0008861873,0.120752],"study_design_scores_gemma":[0.001096099,0.02201468,0.9635767,0.0001192814,0.0004148227,0.002324985,0.0003924567,0.0008713469,0.003146953,0.0001288948,0.005902467,0.00001121923],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965367,0.002602321,0.00005786419,0.0001151164,0.000007593149,0.00001811544,0.00004963492,0.000002262652,0.000610427],"genre_scores_gemma":[0.9985513,0.000904455,0.0001425646,0.0001071845,0.00001599824,0.00001335014,0.0001440142,0.000001339275,0.0001199263],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001084357,"threshold_uncertainty_score":0.003960311,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003721293559937281,"score_gpt":0.238811641408448,"score_spread":0.2350903478485107,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}